Repare Therapeutics Inc. (RPTX) Financial Statements (2023 and earlier)

Company Profile

Business Address 7171 FREDERICK BANTING
SAINT-LAURENT, QC H4S 1Z9
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments343,941,000341,866,000333,710,000
Cash and cash equivalents159,521,000334,427,000326,184,000
Short-term investments184,420,0007,439,0007,526,000
Receivables1,525,000  
Prepaid expense5,715,0006,314,0006,678,000
Other undisclosed current assets2,798,0003,234,0006,164,000
Total current assets:353,979,000351,414,000346,552,000
Noncurrent Assets
Operating lease, right-of-use asset5,371,0007,491,0004,674,000
Property, plant and equipment4,228,0005,604,0003,948,000
Restricted cash and investments   212,000
Deferred income tax assets  3,620,0001,412,000
Other noncurrent assets497,000586,000288,000
Total noncurrent assets:10,096,00017,301,00010,534,000
TOTAL ASSETS:364,075,000368,715,000357,086,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,997,0008,079,0005,476,000
Taxes payable523,00018,000
Employee-related liabilities4,867,0002,771,000
Accounts payable461,0002,302,0002,251,000
Accrued liabilities7,536,000387,000436,000
Deferred revenue53,102,00011,921,0002,073,000
Other liabilities271,000377,000184,000
Other undisclosed current liabilities17,249,00014,712,0003,281,000
Total current liabilities:78,619,00035,089,00011,014,000
Noncurrent Liabilities
Long-term debt and lease obligation:  5,592,0003,308,000
Liabilities, other than long-term debt5,939,00039,613,00055,934,000
Deferred revenue2,682,00039,613,00055,934,000
Operating lease, liability3,257,0005,592,0003,308,000
Total noncurrent liabilities:5,939,00045,205,00059,242,000
Total liabilities:84,558,00080,294,00070,256,000
Equity
Equity, attributable to parent279,517,000288,421,000286,830,000
Common stock482,032,000480,699,000384,313,000
Additional paid in capital37,226,00017,988,0005,875,000
Accumulated other comprehensive loss(428,000)  
Accumulated deficit(239,313,000)(210,266,000)(103,358,000)
Total equity:279,517,000288,421,000286,830,000
TOTAL LIABILITIES AND EQUITY:364,075,000368,715,000357,086,000

Income Statement (P&L) (USD)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Gross profit:  (1,873,000)(890,000)
Operating expenses(151,626,000)(116,260,000)(54,437,000)
Other undisclosed operating income131,830,0009,473,0001,025,000
Operating income (loss):(19,796,000)(108,660,000)(54,302,000)
Nonoperating income (expense)5,896,00074,000(440,000)
Investment income, nonoperating5,631,000259,000240,000
Gain (loss), foreign currency transaction, before tax308,000(144,000)(664,000)
Other nonoperating expense(43,000)(41,000)(16,000)
Income (loss) from continuing operations before income taxes:(13,900,000)(108,586,000)(54,742,000)
Income tax expense (benefit)(15,147,000)1,678,0001,325,000
Loss from continuing operations:(29,047,000)(106,908,000)(53,417,000)
Income (loss) before gain (loss) on sale of properties:(106,908,000)(53,417,000)
Net loss available to common stockholders, diluted:(29,047,000)(106,908,000)(53,417,000)

Comprehensive Income (USD)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(29,047,000)(106,908,000)(53,417,000)
Other comprehensive loss(428,000)  
Other undisclosed comprehensive loss   
Comprehensive loss:(29,475,000)(106,908,000)(53,417,000)
Other undisclosed comprehensive income, net of tax, attributable to parent   
Comprehensive loss, net of tax, attributable to parent:(29,475,000)(106,908,000)(53,417,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: